SCR-LIP-000147 · Claim · machine-readable JSON →

In lipedema patients, pain prevalence and von Frey cutaneous hypersensitivity increased with disease stage (60-100% leg pain across stages, painDETECT >19 only in Stage 3), with reduced dermal Tuj-1+ neuronal density in abdomen and elevated CGRP/NGF in Stage 3 tissues suggesting peripheral neuropathic pain and neurogenic inflammation, independent of BMI.

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Evidence (1)

• Indications of Peripheral Pain, Dermal Hypersensitivity, and Neurogenic Inflammation in Patients with Lipedema — Chakraborty et al. (2022) — refines · cross sectional · 2022
  The article characterizes pain mechanisms (peripheral neuropathic pain, dermal hypersensitivity, neurogenic inflammation) within lipedema across stages, supporting lipedema as a chronic-pain condition, but it does not examine fibromyalgia o

Context (PECO)

Answers these questions

• Is lipedema associated with fibromyalgia and other chronic-pain conditions? refines

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log

• 2026-05-31 — created

← All claims